Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

11/11/2022 06:01

Nov 11 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2022        Sep 30, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               0 mln             5 mln     
                 (-31.9 pct)         (-81.5 pct)       (-67.6 pct)  
  Operating     loss 805 mln        loss 721 mln        loss 1.64   
  Recurring     loss 809 mln        loss 723 mln        loss 1.64   
  Net           loss 810 mln        loss 723 mln        loss 1.64   
  EPS          loss 14.20 yen      loss 14.20 yen    loss 29.63 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T